EUVIMEDEUVIMED entdecken
Open Access

Mechanistic study of PD-L1 regulation of metastatic proliferation in non-small cell lung cancer through modulation of IRE1α/XBP-1 signaling pathway in tumor-associated macrophages

Yi Wang, Lei Yang, Zezheng Liang, Ming Liu

Aging · 2024

DOI: 10.18632/aging.206082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Yi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, B7-H1 Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To explore the related research of PD-L1 in IRE1α/XBP-1 signaling pathway on non-small cell lung cancer. METHODS: The tumor model of mice was established and divided into four groups; after successful modeling, the tumor tissue of mice was removed for subsequent experiments; the bought THP-1 cells were grouped into four different groups, a control group, nivolumab intervention group, IRE1α inhibition group, and nivolumab intervention + IRE1α inhibition group; after co-culture of the four groups of THP-1 cells with A549, THP-1 cell protein levels in the four groups were analyzed using Western blot; A549 cell migration, invasion and proliferation were assessed using the scratch assay, Transwell method, monoclonal experiment and CCK-8 method. RESULTS: In vivo studies indicated that the stimulation of nivolumab could strongly check the progress of NSCLC (non-small cell lung); two groups treated with 4 μ8c showed obvious effects on check point of NSCLC; In vitro experiments including Western-blot experiment, Scratch experiment, Transwell method, Monoclonal experiment and CCK-8 experiment suggest that nivolumab could inhibit migration, invasion and proliferation of NSCLC tumor cells and it. CONCLUSION: PD-L1 is capable of controlling metastatic and proliferative potential of NSCLC by the way of the modification of IRE1α/XBP-1 signaling in tumor-associated macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesCarcinoma, Non-Small-Cell LungLung NeoplasmsB7-H1 AntigenX-Box Binding Protein 1EndoribonucleasesSignal TransductionCell ProliferationTumor-Associated MacrophagesAnimalsHumansMiceCell MovementA549 CellsTHP-1 Cells

Stichwörter der Autor:innen

IRE1α/XBP-1 signaling pathwayP-STAT3PD-L1macrophagenivolumabnon-small cell lung cancer

Substanzen

Protein Serine-Threonine KinasesB7-H1 AntigenX-Box Binding Protein 1EndoribonucleasesERN1 protein, humanCD274 protein, humanXBP1 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Zitieren

APA

Wang, Y., Yang, L., Liang, Z., & Liu, M. (2024). Mechanistic study of PD-L1 regulation of metastatic proliferation in non-small cell lung cancer through modulation of IRE1α/XBP-1 signaling pathway in tumor-associated macrophages. Aging. https://doi.org/10.18632/aging.206082

Vancouver

Wang Y, Yang L, Liang Z, Liu M. Mechanistic study of PD-L1 regulation of metastatic proliferation in non-small cell lung cancer through modulation of IRE1α/XBP-1 signaling pathway in tumor-associated macrophages. Aging. 2024. doi:10.18632/aging.206082

BibTeX
@article{Wang2024,
  author = {Wang, Yi and Yang, Lei and Liang, Zezheng and Liu, Ming},
  title = {Mechanistic study of PD-L1 regulation of metastatic proliferation in non-small cell lung cancer through modulation of IRE1α/XBP-1 signaling pathway in tumor-associated macrophages},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.206082}
}
Kostenlos starten →